IMMUNOMODULATING, METABOLIC AND CARDIOPROTECTIVE EFFECTS OF AT1-ANGIOTENSIN RECEPTORS BLOCKER LOSARTAN IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Teplyakov, A. T. [1 ]
Mayanskaya, S. D. [1 ]
Bolotskaya, L. A. [1 ]
Vdovina, T. V. [1 ]
Stepacheva, T. A. [1 ]
Kuznetsova, A., V [1 ]
Lukinov, A., V [1 ]
Derbeneva, N., V [1 ]
Frants, M., V [1 ]
Shilov, S. N. [1 ]
机构：
[1] Russian Acad Med Sci, State Univ, Sci Res Inst Cardiol, Tomsk Sci Ctr,Siberian Branch, Moscow 109801, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2009年 / 81卷 / 03期
关键词：
RANDOMIZED-TRIAL; CLINICAL STATUS; MORTALITY; ENALAPRIL; INTERVENTION; HYPERTENSION; IRBESARTAN; CAPTOPRIL; SURVIVAL; MODERATE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：62 / 69
页数：8
相关论文
共 50 条
  • [31] Factors influencing accelerated aging in patients with type 2 diabetes mellitus and coronary heart disease
    Huang, Zehua
    Liu, Nana
    Chen, Shiyi
    Chen, Zhiren
    Wang, Peian
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [32] Gender characteristics of lipid metabolism in patients with coronary heart disease and type 2 diabetes mellitus
    Yakovleva, Y. S.
    Ostanina, T. H.
    Voronkova, Y. S.
    Snisar, O. S.
    Voronkova, O. S.
    REGULATORY MECHANISMS IN BIOSYSTEMS, 2023, 14 (01) : 23 - 27
  • [33] Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus
    Liping Li
    Chenxue Qu
    Xuelian Wu
    Juhua Dai
    Yao Lu
    Yan Gong
    Ran You
    Yaqi Liu
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 56 - 65
  • [34] Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus
    Li, Liping
    Qu, Chenxue
    Wu, Xuelian
    Dai, Juhua
    Lu, Yao
    Gong, Yan
    You, Ran
    Liu, Yaqi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 56 - 65
  • [35] Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease
    Shi, Rong
    Wu, Birong
    Niu, Zheyun
    Sun, Hui
    Hu, Fan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 5025 - 5036
  • [36] Local myocardial contractility disturbances in patients with coronary heart disease and Type 2 diabetes mellitus
    Georgadze, Z. O.
    Fomina, I. G.
    Gaydamakina, N. E.
    Frolova, A. I.
    Vargina, T. S.
    Vasilyeva, A. E.
    Galanina, N. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (07): : 36 - 40
  • [37] Therapy of Type 2 Diabetes Mellitus in Patients with Heart Disease
    Kerner, W.
    Motz, W.
    AKTUELLE KARDIOLOGIE, 2013, 2 (01) : 17 - 23
  • [38] Augmentation of coronary flow reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Kawata, T
    Toyoda, T
    Hasegawa, R
    Teramoto, K
    Sekine, T
    Maekawa, S
    Lee, K
    Uchida, D
    Himi, T
    Kuwabara, Y
    CIRCULATION, 2004, 110 (17) : 425 - 425
  • [39] Antiproteinuric effects of losartan in normotensive patients with Type 2 diabetes mellitus and microalbuminuria.
    Zandbergen, AAM
    Baggen, MGA
    Lamberts, SWJ
    Bootsma, AH
    de Zeeuw, D
    Akkerhuis, KM
    Ouwendijk, RJT
    DIABETOLOGIA, 2003, 46 : A338 - A338
  • [40] Prediction of Obesity, Type 2 Diabetes Mellitus, Metabolic Syndrome and Coronary Heart Disease using Backpropagation Algorithm
    Widiyawati
    Nurrahman, A.
    Darmawan, B.
    Jaya, A., I
    Ratianingsih, R.
    INTERNATIONAL CONFERENCE ON MATHEMATICS: PURE, APPLIED AND COMPUTATION, 2019, 1218
12345